Back

H1 antagonist loratadine improves microcirculation in reperfused myocardial infarction

1 September 2025 (10:00 - 10:45)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - Innovations in cardiovascular repair: immune, genetic, and therapeutic perspectives Ischaemia, Infarction, Cardioprotection ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Leon Riehakainen

Cedars-Sinai Medical Centre, Los Angeles (United States of America)

10 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Li (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Doctor G. Damiano (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Doctor Y. Gong (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
Doctor J. Li (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - Innovations in cardiovascular repair: immune, genetic, and therapeutic perspectives

The Event

Event poster

ESC Congress 2025

1 September 2025 10:00 CET
You may be interested in
thumbnail
Congress Presentation
Prolonged mast cell stabilization in reperfused myocardial infarction accelerates hemorrhage resorption and improves remodeling
thumbnail
Congress Presentation
The immediate impact of acute myocardial infarction on cardiac hemodynamics in a porcine model
thumbnail
Congress Presentation
Inhibition of fractalkine signalling reduces intramyocardial haemorrhage and left ventricular thrombus in patients with acute myocardial infarction by modulating immunothrombosis (The FRACTAL trial)

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources